SKI Market

A+| A| A-|

Indian Indices

Sensex

73,583.22 -1,690.23
( -2.25%)

Global Indices

Nasdaq

45,986.51 -463.99
(-1.00%)

Dow Jones

6,496.71 -116.19
(-1.76%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,975.43 -131.41
(-1.30%)

Forex

USD-INR

93.86 0.07
(0.08%)

EUR-INR

108.76 0.06
(0.06%)

GBP-INR

125.66 0.01
(0.01%)

JPY-INR

0.59 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

21.93

100480.08

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.29

Back

visagar financial services ltd

Shree Renuka Sugars reports consolidated net loss of Rs 368.60 crore in the September 2025 quarter

Nov 07,2025

Net Loss of Shree Renuka Sugars reported to Rs 368.60 crore in the quarter ended September 2025 as against net loss of Rs 22.30 crore during the previous quarter ended September 2024. Sales rose 5.03% to Rs 2486.50 crore in the quarter ended September 2025 as against Rs 2367.50 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2486.50	2367.50	5
OPM %	-7.33	9.61	-
PBDT	-328.30	28.70	PL
PBT	-401.30	-41.20	-874
NP	-368.60	-22.30	-1553

73,583.22 -1,690.23 ( -2.25%)

45,986.51 -463.99 (-1.00%)

6,496.71 -116.19 (-1.76%)

53,412.46 -191.19 (-0.36%)

9,975.43 -131.41 (-1.30%)

93.86 0.07 (0.08%)

108.76 0.06 (0.06%)

125.66 0.01 (0.01%)

0.59 0.00 (-0.13%)